Inactive Instrument

News Discovery Laboratories, Inc. Nasdaq

Equities

US2546684034

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Jul. 03	Windtree Therapeutics, Inc. announced that it expects to receive $0.2 million in funding	CI
Jun. 26	Windtree Therapeutics, Inc. announced that it expects to receive $35 million in funding	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Windtree Therapeutics, Inc. announced that it expects to receive $0.2 million in funding	Jul. 02	CI
Windtree Therapeutics, Inc. announced that it expects to receive $35 million in funding	Jun. 25	CI
Windtree Therapeutics : May'24 Corporate Presentation	May. 30	PU
Windtree Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15	CI
Windtree Therapeutics Regains Compliance with Nasdaq	May. 07	AQ
Windtree Therapeutics : April'24 Corporate Presentation	Apr. 24	PU
Reverse Split: 1 of 18	Apr. 21	FA
Windtree Therapeutics Announces Reverse Stock Split	Apr. 18	AQ
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates	Apr. 17	AQ
Windtree Therapeutics Seeks Acquisitions	Apr. 16	CI
Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16	CI
North American Morning Briefing : Stock Futures -2-	Apr. 11	DJ
Transcript : Windtree Therapeutics, Inc. - Shareholder/Analyst Call	Apr. 10
Windtree Therapeutics to Acquire Cancer Treatment From Varian Biopharmaceuticals	Apr. 09	MT
Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing	Apr. 08	AQ
Windtree Therapeutics, Inc. announced that it has received $1.5 million in funding	Apr. 07	CI
Windtree Therapeutics, Inc. acquired All of the assets of Varian Biopharmaceuticals, Inc.	Apr. 07	CI
Windtree Therapeutics, Inc. announced that it expects to receive $1.5 million in funding	Apr. 01	CI
Windtree Therapeutics, Inc. Announces Resignation of John A. Tattory as Interim Chief Financial Officer and Principal Financial Officer	Feb. 16	CI
Windtree Therapeutics, Inc. Announces Resignation of John A. Tattory as Principal Financial Officer	Feb. 16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Discovery Laboratories, Inc. Nasdaq

Equities

US2546684034

Summary

Filters